Senior Vice President & Chief Human Resources Officer
Ms. Crowley joined Azenta Life Sciences in April 2021 as Vice President and Chief Human Resources Officer, responsible for leading the global Human Resources strategy and operations.
Ms. Crowley joined the company after 11 years with Thermo Fisher Scientific where she served as Vice President, Human Resources in a variety of divisions across the organization. Over her 25-year career, she has held various Human Resources leadership roles at Danaher Corporation, Progress Software and RSA Security.
Ms. Crowley holds a bachelor’s degree in Management from Bentley University.
Dr. Sarah Eckenrode
Vice President & General Manager, Sample & Repository Solutions
Dr. Eckenrode joined Azenta Life Sciences in November 2018 and was appointed Vice President of Sample & Repository Solutions business in March 2020. In her role, she is responsible for streamlining the cold chain management workflow along with driving the strategic vision for sample and product management growth.
Dr. Eckenrode started her career with GENEWIZ in 2005 and joined Azenta through the GENEWIZ acquisition in 2018. She has also held a series of senior leadership positions including VP of Customer Support and VP of Sanger and European Operations.
Dr. Eckenrode received her Ph.D. in Biomedical Sciences with a concentration in genetics from the University of Florida and a B.S from Lebanon Valley College.
Linda De Jesus
Senior Vice President & Chief Commercial Officer
Ms. Linda De Jesus joined Azenta Life Sciences on January 2021 as Senior Vice President and Chief Commercial Officer of Azenta Life Sciences when it was known as Brooks Life Sciences. Ms. De Jesus is responsible for leading and managing Azenta Life Sciences’ global commercial function including establishing go-to-market strategy and integrated organization capabilities.
Prior to joining the company, Ms. De Jesus worked for Thermo Fisher Scientific over 8 years in various executive roles, including Vice President and General Manager of Chromatography and Mass Spectrometry Division. She was also Vice President of Global Commercial Operations, with annual sales revenue of $2.6B. Prior to Thermo Fisher Scientific, she worked for Agilent Technologies and Waters Corporation in various senior management roles.
Ms. De Jesus holds an Executive MBA from the University of Connecticut and an undergraduate degree in Chemistry from Columbia University.
Dr. David C. Gray
Senior Vice President, Chief Strategy & New Business Officer
Dr. Gray joined Azenta Life Sciences in July 2014 after having consulted with the Company since November 2013. He leads our next generation product and business initiatives and is also responsible for corporate-level initiatives to guide our strategic moves. Prior to joining the company, Dr. Gray held the position of Chief Strategy and New Business Officer at GT Advanced Technologies, Inc., where he held various executive management roles and was responsible for global strategy development and execution as well as internal product development. He spent several years as an M&A and strategic advisor to various companies in the technology and life science industries.
Dr. Gray has a Bachelors degree in Chemical Engineering from Carnegie Mellon University, Masters and PhD degrees in Chemical Engineering from MIT, and an MBA degree from Stanford University.
Jason W. Joseph
Senior Vice President, General Counsel & Corporate Secretary
Mr. Joseph joined Azenta Life Sciences in March 2011 and is responsible for the Company's legal affairs, including corporate governance, intellectual property, securities, commercial contracts, litigation, compliance and regulatory activities. He also serves as Secretary of the Corporation and to the Board of Directors.
Prior to joining the company, Mr. Joseph served as Vice President, General Counsel and Secretary of Unica Corporation, a leading provider of enterprise marketing management software and services, which was acquired by IBM in October 2010, and as General Counsel and Secretary of MapInfo Corporation, a global provider of location intelligence solutions, which was acquired by Pitney Bowes in April 2007. Mr. Joseph also practiced law at Wilmer Cutler Pickering Hale and Dorr LLP (formerly Hale and Dorr LLP) in Boston, MA.
Mr. Joseph holds a Juris Doctor degree from Northwestern University School of Law and a Bachelor of Arts degree from Loyola University Chicago.
Dr. Matthew McManus
Executive Vice President & Chief Operating Officer
Dr. McManus joined Azenta in January of 2022 as Executive Vice President and Chief Operating Officer. Dr. McManus is responsible for Life Science Products, Services and all commercial operations of the company
Dr. McManus has over 25 years of experience in the life sciences industry and was most recently Senior Vice President and General Manager of the Molecular Diagnostics Division at Bio-Techne following its acquisition of Asuragen, where Dr. McManus was President and CEO. Prior to that, Dr. McManus was the President and CEO of PrimeraDx, led the clinical laboratories at the Cleveland Clinic and held leadership roles at Novartis, McKinsey and Company and Procter and Gamble.
Dr. McManus received his M.D. and Ph.D. from the University of Pennsylvania School of Medicine, his MBA from Boston College and his B.A. in Economics from College of the Holy Cross
Senior Vice President, Corporate Development
Mr. O’Brien joined Azenta Life Sciences in May 2010 and is responsible for corporate development, which includes acquisitions, divestitures, investments and strategic partnerships.
Prior to joining Azenta, Mr. O’Brien served as Senior Director, Corporate Development at EMC and as Vice President, Technology Investment Banking at Cowen and Company. Mr. O’Brien started his career as an accountant with Palomar Medical Technologies and before that Arthur Andersen.
Mr. O’Brien holds an MBA from the University of Chicago, a MS in Accounting from Northeastern University, and a BA from Colby College.
Vice President, Chief Information & Digital Officer
Mr. Paulo joined Azenta Life Sciences in July 2017 as Vice President and Chief Information & Digital Officer. As the Chief Information & Digital Officer Mr. Paulo provides the strategic vision, operational plan, and execution for the technology enablement of the business, enabling the continual positive transformation and progression of the global business.
Mr. Paulo began his career at Automatic Switch Co. in Florham Park New Jersey which was acquired by Emerson Electric Co. based in St. Louis Missouri. Over the course of the next twenty-seven years at Emerson, Mr. Paulo held increasing roles of global responsibility across several key divisions of Emerson, each serving different global industries from healthcare to data centers and telecom: CIO at ASCO Power Technologies, CIO at Energy Systems, CIO at Liebert, and CIO Americas and VP Global Transformation at Emerson’s Network Power business platform which became Vertiv, a $4B annual revenue global business with a footprint in over 147 countries.
Mr. Paulo received his Bachelor’s degree in Electrical Engineering and MBA from Rutgers University. He also holds several certifications spanning the Information Technology & Information Systems profession.
Lindon G. Robertson
Executive Vice President & Chief Financial Officer
Mr. Robertson joined Azenta Life Sciences on October 2013 as Executive Vice President and Chief Financial Officer. Mr. Robertson is responsible for leading and managing Azenta's global financial strategy including establishing long range financial planning and policies while maintaining positive relationships with our shareholders and the financial community.
Prior to joining Azenta, Mr. Robertson was Vice President and Chief Financial Officer of Graftech International, a $1.3 billion global provider of carbon and graphite products for industrial applications. Prior to Graftech International, he worked for the IBM Corporation for over 25 years in various senior financial management roles, including CFO of IBM's global hardware business and CFO of IBM's Japan and China operations.
Mr. Robertson holds an MBA from the University of North Carolina, Chapel Hill and an undergraduate degree in accounting from the University of Texas, Austin.
Dr. Stephen S. Schwartz
President & Chief Executive Officer
Dr. Schwartz joined Azenta Life Sciences in April 2010 as President and was elected to the Azenta board of directors in August 2010. On October 1, 2010, he was appointed as Chief Executive Officer and continues to serve in this capacity. Dr. Schwartz provides the strategic vision and execution to assure Azenta Life Sciences continued growth in the life science markets.
Dr. Schwartz began his career at Applied Materials, Inc. in Santa Clara, California, and over the course of fourteen years held a number of senior leadership roles including head of Applied's High Temperature Films Division and Vice President and General Manager of the Services Division. He was also President of the Company's first software business unit. Following his tenure at Applied, Dr. Schwartz was the President, Chief Executive Officer and Chairman of Asyst Technologies, Inc. for eight years. Since November 2018, Dr. Schwartz has served on the board of directors of Spire Inc., a publicly traded natural gas company.
Dr. Schwartz received his BSEE, MSEE, and Ph.D. degrees in electrical engineering from Purdue University. He also holds an MBA degree from the University of Chicago.
Vice President & Corporate Controller
Ms. Sriram joined Azenta Life Sciences in September 2021 as Vice President of Finance and Corporate Controller and is responsible for oversight of all areas of financial accounting, planning, reporting and controls.
Prior to joining the company, Ms. Sriram worked for over 20 years at General Electric where she most recently was the leader of FP&A in their Aviation division. She also held roles as Chief Financial Officer for GE Additive, Global Controller for GE Aviation, and the FP&A leader for GE’s Middle East, North Africa, and Turkey region. Prior to GE, she spent 5 years in public accounting at Arthur Andersen.
Ms. Sriram holds a Bachelors in Commerce from Delhi University, the Chartered Accountant designation in India, and a CPA license.
Senior Vice President & General Manager, Life Sciences Products
Mr. Vacha was appointed Senior Vice President and General Manager of the Azenta Life Sciences Products division in April 2020, which was formerly known as Brooks Life Sciences. He holds primary responsibility for driving innovation that supports complete sample management solutions for research and drug discovery including compound management, biologics, and gene and cell therapies. Mr. Vacha joined the company in 2014 and has held a series of senior leadership positions including SVP of Global Manufacturing prior to his current role.
Mr. Vacha has an MBA from the MIT Sloan School of Management, a Master of Mechanical Engineering degree from MIT, and a BSME from Kettering University.
Senior Vice President, Global Quality & Regulatory
Mr. Woodward joined Azenta Life Sciences in November 2009 and was appointed Senior Vice President, Global Quality & Regulatory in November 2019. He is primarily responsible for ensuring Azenta products meet customer expectations while complying with all applicable regulatory and standards requirements. Mr. Woodward is on international assignment based in our Manchester, England site.
Over the past decade at Azenta, Mr. Woodward has held engineering and quality leadership roles with increasing responsibilities. Prior to Azenta, Mr. Woodward worked for United Technologies’ Carrier Corporation where he was the engineering leader for compressor systems technology and components group. He also spent over 16 years at General Electric in various engineering leadership roles.
Mr. Woodward holds BS and MS degrees in Chemistry from Furman University.
Dr. Ginger Zhou
Vice President & General Manager, Genomics Services
Dr. Ginger Zhou joined Azenta Life Sciences in November 2018 and was appointed Vice President and General Manager of the Genomic Services business in May 2019. She holds primary responsibility for leading global Genomics business growth, operations, and development of related products and solutions.
Dr. Zhou joined Azenta in November 2018 as part of the acquisition of GENEWIZ. In her 7 years with GENEWIZ, Dr. Zhou held various leadership positions including VP of Global Next Generation Sequencing.
Dr. Zhou received her Ph.D. in Molecular Biology and Biochemistry from The State University of New York through a joint research program with Yale University. She holds a B.S. in Biochemical Engineering from Tianjin University, China.